These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1721836)

  • 1. Identification of three extended antibody-binding segments in recombinant human muscle acetylcholine receptor alpha subunit extracellular domain 1-210.
    Sano M; McCormick DJ; Talib S; Griesmann GE; Lennon VA
    Int Immunol; 1991 Oct; 3(10):983-9. PubMed ID: 1721836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of conformationally dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor alpha subunit expressed in Escherichia coli: implications for myasthenia gravis therapeutic approaches.
    Tsouloufis T; Mamalaki A; Remoundos M; Tzartos SJ
    Int Immunol; 2000 Sep; 12(9):1255-65. PubMed ID: 10967020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit. Dissecting a potentially myasthenogenic epitope.
    Tzartos SJ; Remoundos MS
    Eur J Biochem; 1992 Aug; 207(3):915-22. PubMed ID: 1379917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Main immunogenic region of Torpedo electroplax and human muscle acetylcholine receptor: localization and microheterogeneity revealed by the use of synthetic peptides.
    Tzartos SJ; Loutrari HV; Tang F; Kokla A; Walgrave SL; Milius RP; Conti-Tronconi BM
    J Neurochem; 1990 Jan; 54(1):51-61. PubMed ID: 1688377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenogenicity in the main immunogenic region of acetylcholine receptor as modified by conformational design: an approach to antigenic synthetic peptides.
    Takamori M; Hamada T; Okumura S
    J Neurol Sci; 1992 Jun; 109(2):182-7. PubMed ID: 1634900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenogenicity of a human acetylcholine receptor alpha-subunit peptide: morphology and immunology.
    Matsuo H; Tsujihata M; Satoh A; Takeo G; Yoshimura T; Nagataki S
    Muscle Nerve; 1992 Mar; 15(3):282-7. PubMed ID: 1372965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenogenic significance of synthetic alpha-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor.
    Takamori M; Okumura S; Nagata M; Yoshikawa H
    J Neurol Sci; 1988 Jun; 85(2):121-9. PubMed ID: 3260271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.
    Venkatesh N; Im SH; Balass M; Fuchs S; Katchalski-Katzir E
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):761-6. PubMed ID: 10639153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of human recombinant acetylcholine receptor alpha subunit: cytoplasmic epitopes dominate the antibody response in four mouse strains.
    Palace J; Vincent A; Beeson D; Newsom-Davis J
    Autoimmunity; 1994; 18(2):113-9. PubMed ID: 7537978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.
    Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N
    J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping of antibodies to acetylcholine receptor alpha subunits using peptides synthesized on polypropylene pegs.
    Das MK; Lindstrom J
    Biochemistry; 1991 Mar; 30(9):2470-7. PubMed ID: 1705819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.
    Schwimmbeck PL; Dyrberg T; Drachman DB; Oldstone MB
    J Clin Invest; 1989 Oct; 84(4):1174-80. PubMed ID: 2551924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the alpha subunit.
    Tzartos SJ; Kokla A; Walgrave SL; Conti-Tronconi BM
    Proc Natl Acad Sci U S A; 1988 May; 85(9):2899-903. PubMed ID: 3362855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
    Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
    Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myasthenia gravis: pathogenesis and therapeutic approach on the basis of molecular structure and immunogenicity of acetylcholine receptor].
    Takamori M
    Nihon Rinsho; 1994 Nov; 52(11):3038-45. PubMed ID: 7996707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
    Loutrari H; Tzartos SJ; Claudio T
    Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
    Yuen MH; Macklin KD; Conti-Fine BM
    J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.
    Zisman E; Katz-Levy Y; Dayan M; Kirshner SL; Paas-Rozner M; Karni A; Abramsky O; Brautbar C; Fridkin M; Sela M; Mozes E
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4492-7. PubMed ID: 8633096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.